Skip to search formSkip to main contentSkip to account menu

abacavir 600 MG / dolutegravir 50 MG / Lamivudine 300 MG Oral Tablet [Triumeq]

Known as: DOLUTEGRAVIR SODIUM 50 mg / ABACAVIR SULFATE 600 mg / LAMIVUDINE 300 mg ORAL TABLET, FILM COATED [Triumeq], abacavir 600 MG / dolutegravir 50 MG / 3TC 300 MG Oral Tablet [Triumeq], ABACAVIR SULFATE 600 mg / DOLUTEGRAVIR SODIUM 50 mg / LAMIVUDINE 300 mg ORAL TABLET, FILM COATED [Triumeq] 
National Institutes of Health

Related topics

Related topics

18 relations
LamivudineMagnesium stearateMannitolOral Tablet

Broader (1)

abacavir / dolutegravir / Lamivudine Oral Tablet [Triumeq]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects
The unexpected identification of a neural tube defect (NTD) safety signal with preconception dolutegravir (DTG) exposure in the… 
Review
2019
Review
2019
New Dual Combination of Dolutegravir-Rilpivirine for Switching to Maintenance Antiretroviral Therapy.
Advances in antiretroviral therapy have led to dramatic improvements in survival of HIV-infected persons. However, HIV cure… 
2019
2019
PIN31 DOLUTEGRAVIR PLUS LAMIVUDINE FOR THE TREATMENT OF ART NAIVE ADULTS LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV): A US COST-UTILITY ANALYSIS
2018
2018
Safety, Tolerability, and Efficacy of Generic Dolutegravir-containing Antiretroviral Therapy Regimens Among South Indian Human Immunodeficiency Virus-infected Patients
In this first study of generic dolutegravir (DTG)-containing regimens in a low-resource setting, we assessed safety, tolerability… 
2018
2018
PIN64 - DOLUTEGRAVIR PLUS LAMIVUDINE FOR THE TREATMENT OF NAÏVE ADULTS LIVING WITH HIV-1: A UK COST-MINIMIZATION ANALYSIS
2016
2016
Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing
Dolutegravir is licenced for use in both adults and children over 12 years of age, although data are limited on its use in… 
2015
2015
Dolutegravir Resistance Mutation R263K Cannot Coexist in Combination with Many Classical Integrase Inhibitor Resistance Substitutions
ABSTRACT The new integrase strand transfer inhibitor (INSTI) dolutegravir (DTG) displays limited cross-resistance with older… 
2014
2014
A-26: Association Foscarnet (PFA)/ Dolutegravir (DTG), dans le traitement des infections VIH avancées : une série de 5 cas
2012
2012
Dolutegravir Noninferior to Raltegravir in Treatment-Naive HIV-Infected Patients
The integrase inhibitor raltegravir is a recommended option for initial HIV treatment, and a second integrase inhibitor… 
2011
2011
Therapeutische Zusammensetzung enthaltend Dolutegravir, Abacavir und Lamivudine
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)